How to find the next 10-bagger (Part III)

A series of articles examining past 10-baggers

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In this series of articles, I am taking a look at the history of some of the ASX's best performing stocks. In particular, I hope to address the following questions.

  1. What did these companies look like at the start of their rise?
  2. Is it possible to identify tomorrow's 10 baggers?

Magellan Financial Group Ltd (ASX: MFG) is a fund manager specialising in international investments offered to both retail and institutional clients. If you had bought $10,000 of shares in the company at the beginning of March 2009, they would be worth more than $700,000 today plus you would have also received dividends totalling $70,000.

Admittedly, buying shares in a fund manager at the height of the GFC would not have been easy given market sentiment at the time. However, Magellan was trading at a 50% discount to net assets half of which were unencumbered cash and so there was little chance of losing money.

When Magellan was launched at the end of 2006, the company raised $100 million to ensure that there would be no financial pressure to chase short-term results. This is an example of the long-term approach of founders Hamish Douglass and Chris Mackay who are both still major shareholders in the company today.

Prior to Magellan, Hamish Douglass was co-head of Global Banking at Deutsche Bank in Australasia and Chris Mackay was CEO of UBS in Australia. Their backgrounds implied that they had both the contacts to market Magellan's funds effectively and the skillset to wisely manage international investments.

Magellan was and is still different to most other Australian retail fund managers in that it only manages international funds. In 2009 it may not have been possible to foresee the subsequent surge in popularity of overseas investing, but Magellan was clearly targeting a gap in the market at that time.

It was also clear that management and shareholder interests were well aligned as Hamish Douglass and Chris Mackay gave up considerable compensation in 2008 in return for equity in Magellan. They had previously been entitled to large management and performance fees but from March 2008 were paid a flat $250,000 per year.

Along with non-executive director Paul Lewis, the pair also bought a significant number of shares on market in October and November 2008. Paul Lewis bought 250,000 shares which are worth more than $6 million today whilst Hamish Douglass purchased 150,000 and Chris Mackay bought 80,000.

Not only were the interests of management and shareholder aligned, but Magellan also invested directly in its managed funds. This demonstrates that management were not chasing short-term performance fees at the expense of long-term returns.

Perhaps another sign of things to come was that the unlisted Magellan Global Fund delivered a return of 2% in the year to 30 September 2008, outperforming its benchmark by 20%. Although a year is generally too short a time period to judge investment ability, it is certainly more difficult to perform well when markets are in turmoil.

Fund management companies can make fantastic businesses because they have the potential to grow quickly using little capital. However, success depends on the ability of those in charge which is often hard to evaluate.

In 2009 the background, share purchases, investment approach and communication style of Magellan's management team provided hints of the company's rosy future. The fact that it was selling for less than half its asset backing made it an extremely low-risk investment proposition.

Motley Fool contributor Matt Brazier has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »